OKYO Pharma Limited (OKYO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    OKYO Pharma Limited

    NASDAQ: OKYO · Real-Time Price · USD
    2.05
    0.07 (3.54%)
    At close: Oct 03, 2025, 3:59 PM
    2.04
    -0.49%
    After-hours: Oct 03, 2025, 07:42 PM EDT

    OKYO Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Cash & Equivalents
    		 1.56M 826.85K 4.05M 2.7M 6.89M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a n/a
    Receivables
    		 1.89M 580.94K 980.08K 883.43K 4.5K
    Inventory
    		 n/a n/a 170.31K -1.49K 34.00
    Other Current Assets
    		 n/a n/a -170.31K 1.49K 71.75K
    Total Current Assets
    		 3.68M 1.54M 5.2M 4.3M 6.99M
    Property-Plant & Equipment
    		 2.04K 3.35K 7.22K 5.22K 104.64K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 2.04K 3.35K 7.22K 5.22K 104.64K
    Total Assets
    		 3.68M 1.54M 5.2M 4.3M 7.09M
    Account Payables
    		 7.9M 6.13M 1.02M 517.67K 210.99K
    Deferred Revenue
    		 n/a n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 2.22M n/a 34.14K
    Other Current Liabilities
    		 n/a n/a 1.29M 323.06K 1.43M
    Total Current Liabilities
    		 9.23M 7.42M 7.26M 1.35M 1.71M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a n/a n/a 64.61K
    Total Liabilities
    		 9.23M 7.42M 7.26M 1.35M 1.77M
    Total Debt
    		 n/a n/a 2.22M n/a 98.76K
    Book Value
    		 -5.55M -5.88M -2.05M 2.95M 5.32M
    Book Value Per Share
    		 -0.14 -0.2 -0.09 0.20 0.51
    Common Stock
    		 146.72M n/a n/a 123.98M 111.63M
    Retained Earnings
    		 -143.02M -142.52M -125.7M -112.43M -106M
    Comprehensive Income
    		 -11.47M -11.31M -7.74M -11.01M 12.82M
    Shareholders Equity
    		 -5.55M -5.88M -2.05M 2.95M 5.32M
    Total Investments
    		 n/a n/a n/a n/a n/a

    Add to Watchlist